Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy
Michael Schnekenburger,
Anne Lorant,
Sruthi Reddy Gajulapalli,
Ridhika Rajora,
Jin‐Young Lee,
Aloran Mazumder,
Haeun Yang,
Christo Christov,
Hyoung Jin Kang,
Bernard Pirotte,
Marc Diederich
Affiliations
Michael Schnekenburger
Laboratoire de Biologie Moléculaire et Cellulaire du Cancer Luxembourg Luxembourg
Anne Lorant
Laboratoire de Biologie Moléculaire et Cellulaire du Cancer Luxembourg Luxembourg
Sruthi Reddy Gajulapalli
Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University Seoul Republic of Korea
Ridhika Rajora
Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University Seoul Republic of Korea
Jin‐Young Lee
Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University Seoul Republic of Korea
Aloran Mazumder
Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University Seoul Republic of Korea
Haeun Yang
Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University Seoul Republic of Korea
Christo Christov
Faculté de Médecine Université de Lorraine Vandœuvre‐lès‐Nancy France
Hyoung Jin Kang
Department of Pediatrics Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital Seoul Republic of Korea
Bernard Pirotte
Laboratory of Medicinal Chemistry Center for Interdisciplinary Research on Medicines (CIRM) University of Liège Liège Belgium
Marc Diederich
Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University Seoul Republic of Korea